Neilwardy

Headache: The Journal of Head and Face Pain banner

Abstract Background Comprehensive literature reviews of historical perspectives and evidence supporting cannabis/cannabinoids in the treatment of pain, including migraine and headache, with associated neurobiological mechanisms of pain modulation have been well described. Most of the existing literature reports on the cannabinoids Δ9‐tetrahydrocannabinol (THC) and cannabidiol (CBD), or cannabis in general. There are many cannabis strains …

Headache: The Journal of Head and Face Pain banner Read More »

Cannabidiol in medical marijuana: Research vistas and potential opportunities

The high and increasing prevalence of medical marijuana consumption in the general population invites the need for quality evidence regarding its safety and efficacy. Herein, we synthesize extant literature pertaining to the phytocannabinoid cannabidiol (CBD) and its brain effects. The principle phytocannabinoid Δ9-tetrahydrocannabinol (Δ9-THC) and CBD are the major pharmacologically active cannabinoids. The effect of …

Cannabidiol in medical marijuana: Research vistas and potential opportunities Read More »

UK epilepsy drug to become first cannabis-based medicine in US Epidiolex set for autumn launch after US Food and Drug Administration gives approval

Marijuana plant Epidiolex is a purified form of cannabidiol, one of the hundreds of molecules found in the marijuana plant. Photograph: Martin Schroeder/Getty Images/EyeEm A treatment for childhood epilepsy developed by a UK firm has been approved by US regulators and will become the first cannabis-based medicine on the American market. Epidiolex, made by GW …

UK epilepsy drug to become first cannabis-based medicine in US Epidiolex set for autumn launch after US Food and Drug Administration gives approval Read More »